This unit has a Phase 1 unit that is among the few Phase 1 units in Canada located within a major tertiary care facility: in this case, the University Hospital. The 3,300-square-foot, eight-bed ward is designed to assess drug safety, pharmacokinetics, pharmacodynamics, and tolerability in a controlled environment. You can conduct Phase 1–4 studies on your own or use our staff with their full range of clinical investigations experience.